About Ayal Ronen
This author has not written his bio yet.
But we are proud to say that Ayal Ronen contributed 360 entries already.
Entries by Ayal Ronen
Turning Non-Dilutive Funding into a Strategic Source of Funding
Non dilutive R&D funding – mainly multibillion programs of Federal agencies – has become a major player in the life science finance industry. Today more than ever, NIH, DOD, NSF, CDC and dozens of other agencies, both federal and private, support biological and medical preclinical and clinical activities in all fields and scopes of research […]
Attending to the Interests and Needs of the Bio Defense Community
Over the past decade, the United States government has allocated nearly $55 billion on preparing the nation against biological threats. The Obama administration has maintained that momentum with a total biodefense budget of $6.05 billion for FY2012, going primarily to the NIH and DOD. Additional civilian biodefense funds have been budgeted to the DHS, USDA, […]
SBIR/STTR & Beyond – Common Misperceptions
One of the most common misperceptions relating to non-dilutive funding for life science R&D is that the SBIR/STTR program is the main and even only funding resource available for the life science industry. Companies and investors alike must know that although it is an important and sometimes relevant program, the SBIR/STTR program is a small, […]
Last Minute Applications
Writing proposals for Federal grants is a time consuming task that requires much planning and administration. This process typically takes 3-6 weeks to complete for a standard high quality application; more complex applications may take longer. However, the brief periods often allotted between release of a funding opportunity announcement and its deadline, as well as […]
The Path to Large Scale Funding Opportunities
As life science research is becoming more complicated, requiring collaborative activity and significant resources, funding agencies, such as NIH and DOD, have shifted significant portions of their budgets towards supporting large scale, multi-project clinical activities of both academic institutions and companies. The funding agencies put forth great effort in creating and allocating budgets to programs […]
Join the FreeMind Network – Become our Partner!
FreeMind sustains a growing network of leading companies and organizations, all with a strong and common interest in assisting the life science market and creating a common ground and collaborative framework for academia-industry collaborations. Our extensive and intimate understanding of the market, coupled with our designated knowledge of non dilutive funding sources and their promotion […]
Website Links
Address
FreeMind Group
6 Liberty Square #2783
Boston, MA 02109